Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | HPRT1 | P00492 | 6/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | NOS1 | P29475 | 2/20 | 0.32 |
| ▸ | NOS3 | P29474 | 1/20 | 0.32 |
| ▸ | NOS2 | P35228 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | PNP | P00491 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1586365 | 0.78 | PNP (0.37) | HPRT1NOS1NOS3NOS2PNP | |
| SCHEMBL9278710 | 0.73 | HPRT1 (0.54) | NPSR1HPRT1MEN1KMT2ANOS1 | |
| SCHEMBL9542610 | 0.72 | NPSR1 (0.43) | NPSR1HPRT1MEN1KMT2A | |
| SCHEMBL27856551 | 0.71 | MEN1 (0.56) | MEN1KMT2APNP | |
| Hydrochloric Acid SCHEMBL9543633 | 0.71 | NPSR1 (0.42) | NPSR1HPRT1MEN1KMT2A | |
| SCHEMBL9544073 | 0.69 | NPSR1 (0.37) | NPSR1HPRT1MEN1KMT2AALDH1A1 | |
| SCHEMBL8952338 | 0.68 | ALDH1A1 (0.38) | MEN1KMT2AALDH1A1 | |
| Iodide SCHEMBL30340044 | 0.66 | TYMS (0.39) | ALDH1A1PNP | |
| Iodide SCHEMBL10861768 | 0.66 | PNP (0.47) | HPRT1MEN1KMT2APNP | |
| Iodide SCHEMBL10856292 | 0.65 | BLM (0.46) | HPRT1MEN1KMT2AALDH1A1PNP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190211368-A1 | TRINUCLEOTIDE MRNA CAP ANALOGS | MODERNATX, INC. | 2019-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190211368-A1 | TRINUCLEOTIDE MRNA CAP ANALOGS | RNGTT, RNMT, CPSF7 | NPSR1 3129/4885HPRT1 1225/4885MEN1 4726/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.